Related Articles
Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: A single institution retrospective analysis
Therapeutic effect and adverse reaction of sorafenib in the treatment of advanced renal cancer
Efficacy and safety of oxaliplatin, bevacizumab and oral S‑1 for advanced recurrent colorectal cancer
Gefitinib as first line therapy in Malaysian patients with EGFR mutation-positive non-small-cell lung cancer: A single-center retrospective study